Canada Markets open in 8 hrs 18 mins

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3750+0.0023 (+0.62%)
At close: 04:00PM EST
0.3752 +0.00 (+0.05%)
After hours: 07:27PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.9950
52 Week Low 30.3550
50-Day Moving Average 30.4710
200-Day Moving Average 30.8909

Share Statistics

Avg Vol (3 month) 34.56M
Avg Vol (10 day) 31.65M
Shares Outstanding 5182.78M
Implied Shares Outstanding 6N/A
Float 8179.71M
% Held by Insiders 10.62%
% Held by Institutions 14.24%
Shares Short (Dec. 14, 2021) 44.19M
Short Ratio (Dec. 14, 2021) 41.27
Short % of Float (Dec. 14, 2021) 42.41%
Short % of Shares Outstanding (Dec. 14, 2021) 42.29%
Shares Short (prior month Nov. 14, 2021) 45.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.41%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.98M
Net Income Avi to Common (ttm)-98.57M
Diluted EPS (ttm)-0.7690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)32.01M
Total Debt/Equity (mrq)61.04
Current Ratio (mrq)5.06
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-22.41M
Levered Free Cash Flow (ttm)-30.12M